Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)
Keshu Zhou(Zhengzhou University), Jianyong Li(Lanzhou Institute of Husbandry and Pharmaceutical Sciences), Meifang Zheng, Yifan Zhai(ASKA Pharmaceutical (Japan)), Xin Zhou(Wuxi People's Hospital), Zi Chen(Central South University), Zhiling Yan(Xuzhou Medical College), Shuangnian Xu(Army Medical University), Jianfei Fu(Jinhua Central Hospital), Ru Feng(Southern Medical University), Jianhua Qu, Yang Liang(Sun Yat-sen University), Wenzheng Yu(Binzhou Medical University), Zhiyan Liang(East China University of Science and Technology), Yuping Zhong(Qingdao University), Jishi Wang(Guiyang Medical University), Ting Niu(Sichuan University), Yinghua Geng(First Affiliated Hospital of Bengbu Medical College), Qianqian Xiang(Jinan University), Lie Lin(Hainan General Hospital), Shan Zeng(Central South University), Fei Li(Nanchang University), Yajun Li(Hunan Cancer Hospital), Xiaoping Zhang(Soochow University), Caixia Li(Soochow University), Zhao Wang(Dalian University of Technology), Lei Wang(Northwestern University), Lihong Liu(Hebei Medical University), Rong Fu(Tianjin Medical University General Hospital), Bin Lü(Fudan University), Min Yu(Fujian Medical University), Xiongpeng Zhu(Fujian Medical University), Hui Zeng(Dalian Medical University), Yiming Luo(First Affiliated Hospital of Xiamen University), Ying Zhao(First People's Hospital of Foshan), Yajing Xu(Central South University), Suijing Wu(Guangdong General Hospital), Tingyu Wang(Shanghai Jiao Tong University), Chunyan Ji(Jiangsu University of Science and Technology), Sujun Gao(Jilin University), Xiaobing Huang(University of Electronic Science and Technology of China), Hongling Peng(Central South University), Guohui Cui(Huazhong University of Science and Technology), Lichuang Men, Rui Huang(Wenzhou Medical University), Wenbin Qian(Second Affiliated Hospital of Zhejiang University), Xiaoyu Zhu(Jilin University), Yingmin Liang(Tang Du Hospital), Jie Jin(First Affiliated Hospital Zhejiang University)
Cited by 0
Related Papers
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Nitrogen-doped porous carbons through KOH activation with superior performance in supercapacitors
|Carbon|2013|392
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
|EBioMedicine|2016|345
Strategies and insights towards the intrinsic capacitive properties of MnO2 for supercapacitors: Challenges and perspectives
|Nano Energy|2018|323
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
|Annals of the Rheumatic Diseases|2020|301